Pharmacokinetics of Deferiprone in Patients with β-Thalassaemia

Inherited haemoglobin disorders: an increasing global health problem.

D. J. Weatherall, J. B. Clegg · PubMed · 2001 · 1.2K citations · Full text

Genetic Epidemiology, High Frequency, Non-communicable Disease +16

The Thalassæmia Syndromes.

The Medical Journal of Australia · 1973 · 812 citations

Clinical Disorders, Pediatric Hematology, Hematology +3

Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major

Caterina Borgna‐Pignatti · Blood · 2005 · 372 citations · Full text

Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis.

Antonio Piga, Carmen Maria Gaglioti, Eugenia Fogliacco et al. · PubMed · 2003 · 222 citations

Long-Term Trial of Deferiprone in 51 Transfusion-Dependent Iron Overloaded Patients

A. V. Hoffbrand, F. N. Al‐Refaie, Bernard A. Davis et al. · Blood · 1998 · 205 citations · Full text